Stratasys Ltd. (NASDAQ: SSYS), a leader in polymer 3D printing and additive manufacturing solutions, today announced it has partnered with Siemens Healthineers to carry out a landmark research project designed to develop new state-of-the-art solutions for the advancement of medical imaging phantoms for computed tomography (CT) imaging.

At ABLE Human Motion, they believe the best way to design compelling and really useful exoskeleton technology is by involving the final users from the beginning. This implies fast design iterations incorporating the patient’s feedback, and this is where 3D printing excels.

Transforming ABLE’s Product Development

ABLE Human Motion is a medical device start-up based in Barcelona with the mission of enabling mobility for everyone. They design, develop, and commercialize exoskeleton technology to empower people with disabilities, by providing better mobility and increased independence.

The New 25µm Resolution Printer Combines Part Quality and Speed for End-Part Production

Boston Micro Fabrication (BMF), the pioneer in microscale 3D printing systems, today unveiled the microArch™ S350, the latest addition to its roster of industrial-grade micro-precision 3D printers. This next-generation version of BMF’s 25µm resolution system offers the highest throughput in the company’s portfolio, combining high part quality with the print speed required for end-part production.

Platform can perform automatic analysis of sample's purity, identification and degradation of compounds through calibrated algorithm-based digital references.

Accelerates digitalization in labs and manufacturing by offering traceable digital records of physical reference materials
Allows Pharma QC/QA and R&D to increase sampling rate and identify sample inconsistencies to ensure safer products

Stratasys Ltd. (NASDAQ: SSYS), a leader in polymer 3D printing solutions, today announced its intent to expand its relationship with Encee GmbH. Encee GmbH is a long-time Stratasys Platinum Partner in Germany and as part of this agreement, Encee GmbH will establish a new division called Encee Medical to support the medical market in Germany.

Animal free 3D bioprinting

Biofabrication or 3D bioprinting aims to create tissue constructs for numerous applications including animal free testing, drug screening and regenerative medicine. One crucial aspect of the technology is the use of suitable materials to enable the 3D printing of living cells which are called bioinks. These ‘bio inks’ must support the cells and keep them alive during and after the printing process.

At Formnext 2023, the leading event for Additive Manufacturing and industrial 3D printing in Frankfurt, Elkem will display its extensive portfolio of silicone solutions for this innovative technology.

Elkem will showcase silicones parts printed with the AMSil™ & AMSil SILBIONE™ range, an innovative technology recognized as a winner of R&D 100 award, at the upcoming Formnext show in Germany from November 7th to November 10th 2023.

The global medical device technology market is expected to grow by nearly 5% in the next four years, with additive manufacturing (AM) playing an increasingly important role — enabling the production of parts ranging from diagnostic equipment components and surgical tools to elements for life-changing orthoses and implants. It’s also a manufacturing process that must, like any other for this sector, employ specific safeguards and processes to guarantee the consistent quality of parts produced.

As a leading manufacturer of advanced adhesive solutions for the medical industry, Henkel has launched a novel medical grade light cure adhesive designed for devices that are to be worn on the body. The new product is formulated without IBOA (Isobornyl Acrylate) or any other known skin sensitizing monomers. The adhesive is also formulated to conform to EU MDR 2017 regulations concerning use of CMR (carcinogenic, mutagenic, or toxic for reproduction) substances in medical devices making it a robust option for new designs.

Elkem will showcase silicones parts printed with the AMSil™ & AMSil SILBIONE™ range, an innovative technology recognized as a winner of R&D 100 award, at the upcoming Formnext show in Germany from November 7th to November 10th 2023.
This range enables the production of functional parts from genuine 100% silicone elastomers by Additive Manufacturing/3D Printing using the LDM technology. These products address the megatrends challenges and offer two series:

German-based digital manufacturing company Replique, focused on creating simple and sustainable industrial processes, has leveraged HP’s industry leading Multi Jet Fusion technology to change the way wheelchairs are designed and manufactured, making production more efficient, cost-effective, and personalized to the end user.

Rising kidney transplant demands underscore a pressing global health concern. While 3D-printed organs promise a potential solution, challenges in printing speed and accuracy persist. Leading the way, Vidmantas Šakalys of Vital 3D provides valuable insights and hints at a transformative solution on the horizon.